Through an understanding of basic mechanisms of health and disease and comparative biology of animal species, research conducted within the Midlothian Science Zone can enhance human health.
Public health problems caused by environmental contamination and emerging infectious diseases are a growing concern worldwide. These public health threats are affected by the relationship between people and the physical, chemical, and biological nature of our natural environments.
With its proximity to Edinburgh, the Midlothian region is supported by the critical mass of world-leading research, research excellence in a number of life science fields and a focus on collaboration as a means to advance research and commercialisation.
The area boasts access world-leading research organisations which include four universities and three university teaching hospitals that together house a further 11 institutes dedicated to the life sciences, in addition to the numerous centres of excellence.
This highly integrated life sciences community is structured to maintain a world-leading research position. This is managed through effective multidisciplinary research groups, research pooling and knowledge transfer which has made research in Edinburgh and the Lothians more efficient, more thorough and more innovative.
Midlothian and Human Health
One location, one health. Midlothian is a location of choice for its proximity to researchers in human health, covering a diverse range of research areas from stem cell research, through human diseases.
The University of Edinburgh undertakes research into important areas of medical research that are relevant to life today, and aims to understand, alleviate and eradicate the disease and health problems of modern society. Edinburgh excels at research into inflammation, cardiovascular disease, reproductive biology, immunology, cancer, infectious disease and neuroscience.
Genetics research aims to identify the molecular and cellular mechanisms underlying normal human development and disease through world-leading research. This includes the use of modern technology to advance research into genetic manipulation and epigenetics.
Edinburgh Genomics is the largest academic sequencing facility in Europe, catering for whole genome sequencing of human and animal genomes as well as an exceptional range of bespoke genomic applications from ChIp-seq, RNA-seq and targeted sequencing, to long-read sequencing of small and large genomes.
This leading-edge technology places Edinburgh and the Lothians at the forefront of the revolution in genome technology and information and is driving a sea-change in biomedical research, clinical practice and agricultural breeding strategies.
Stem Cell Research
Stem cell research and regenerative medicine have the potential to significantly impact on a broad range of life science subjects.
The MRC Centre for Regenerative Medicine (CRM) is a research institute based at the University of Edinburgh. Scientists and clinicians study stem cells, disease and tissue repair to advance human health.
The Centre is based at the Scottish Centre for Regenerative Medicine (SCRM) building, on the Edinburgh BioQuarter campus next to the Royal Infirmary Hospital and the University's Clinical Research facilities. With new state-of-the-art facilities and a 230+ team of scientists and clinicians, CRM is positioned uniquely to translate scientific knowledge to industry and the clinic.
Research and Development
Scotland has emerged as world-leader in many fields including cancer research, cardiovascular research, neuroscience, genomics, proteomics and bioinformatics, signal transduction biology, stem cell research, virology and immunology.
From broad life science fields to specialist life science subjects, Edinburgh and the Lothians is exceptional at a number of areas with a major focus on human health.
The Queen's Medical Research Institute (QMRI), one of five research institutes at the College of Medicine and Veterinary Medicine, is a world class clinical research facility addressing major disease challenges. Research is broadly focussed on normal and diseased cells and inflammation and tissue repair.
The drug discovery industry is evolving rapidly, this evolution is stimulated by increased accessibility of new technologies such as next generation sequencing, systems biology and imaging that enhance our ability to interrogate complex biological systems.